This almost 2 million dollars awarded by the Natio
Post# of 148260
I found it interesting that the NIH thought we could develop a once a quarter Prep dose for HIV. Nader had talked about monthly but a quarterly injection is way better. Can you imagine the market for prep with only positive side effects? Not like other drugs with a 5 minute list of side effects that are detrimental to you.
This is something to look forward to in a couple of years. I don’t know what the prospects are for a label extension but seems like we will have to have a trial or two before it receives an approval.